-+ 0.00%
-+ 0.00%
-+ 0.00%

ALNYLAM COLLABORATOR REGENERON ADVANCES CIDEBSIRNA WITH PROMISING FIRST-IN-HUMAN RESULTS IN PATIENTS WITH MASLD

Reuters·11/10/2026 15:00:02

Please log in to view news